ISWM
ABBV icon

Intesa Sanpaolo Wealth Management’s AbbVie ABBV Stock Holding History

Intesa Sanpaolo Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Buy
1,069
+599
+127% +$129K 0.05% 141
2026
Q1 		$102K Buy
470
+45
+11% +$9.98K 0.02% 176
2025
Q4 		$97.1K Buy
+425
New +$96.8K 0.02% 166

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Intesa Sanpaolo Wealth Management's ABBV Position: Q2 2026 in Review

Intesa Sanpaolo Wealth Management increased its AbbVie (ABBV) stake by 127% in Q2 2026, buying an estimated $129K and bringing the position to 1,069 shares worth $269K. The position accounts for 0.05% of the portfolio, ranked #141.

Intesa Sanpaolo Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Intesa Sanpaolo Wealth Management held 1,069 shares of AbbVie worth $269K as of Q2 2026.
  • Intesa Sanpaolo Wealth Management bought 599 AbbVie shares in Q2 2026, an estimated $129K.
  • AbbVie made up 0.05% of Intesa Sanpaolo Wealth Management's portfolio in Q2 2026, its #141 holding.
  • Intesa Sanpaolo Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Intesa Sanpaolo Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.